News & Investors - Lumicell Inc

BREAKING NEWS: We are pleased to announce FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ DVS. To the hundreds of women and dedicated investigators who participated in this important clinical work that brought us to where we are today, THANK YOU! We wouldn’t be here without your support.

News & Investors

News

Lumicell Granted Fast Track Designation Approval by the FDA for Breast Cancer Treatment

November 17, 2020

Lumicell Announces Initiation of NIH/NCI Academic-Industry Study of its LUM Imaging System

September 29, 2020

Howard Hechler Joins Lumicell as Senior Vice President of Strategy & Business Development

September 16, 2020

Lumicell Initiates Pivotal Trial for Breast Cancer Surgical Guidance Solution

November 5, 2019

Lumicell Completes Enrollment of Phase C Feasibility Trial for Breast Cancer Surgical Guidance Solution

August 19, 2019

Feasibility Study Underway to Assess Lumicell Technology for Removing Ovarian and Peritoneal Cancer Tumors During the First Surgery

April 10, 2019

Lumicell Headquarters Expands Into New Boston-Area Office Space

February 22, 2019

Lumicell Presents Phase 2 Clinical Data Showing LUM System Provided

December 17, 2017

Lumicell Expands Development Strategy and Pipeline Across Five Solid Tumor Cancers Supported by $28.7 Million Series C Financing

December 7, 2017

Events

San Antonio Breast Cancer Symposium^®,
December 10-14, 2024
Henry B. Gonzalez Convention Center

Investors